Lymphocytes Stocks List Ranked for 2024 | NYSE,

Symbol	Grade	Name	% Change
TGTX	B	TG Therapeutics, Inc.	1.51
GDTC	C	CytoMed Therapeutics Limited	2.70
IBRX	C	ImmunityBio, Inc.	1.29
CELU	D	Celularity Inc.	-3.16
GRI	D	GRI Bio, Inc.	0.00
TIL	D	Instil Bio, Inc.	5.61
IOVA	F	Iovance Biotherapeutics, Inc.	3.76
NKGN	F	NKGen Biotech, Inc.	3.70
INDP	F	Indaptus Therapeutics, Inc.	-4.31

Related Industries: Biotechnology Conglomerates

Symbol	Grade	Name	Weight
BBP	C	BioShares Biotechnology Products Fund	4.25
PBE	C	PowerShares Dynamic Biotech & Genome	3.78
IDNA	F	iShares Genomics Immunology and Healthcare ETF	3.07
PSCH	B	PowerShares S&P SmallCap Health Care Portfolio	2.64
XBI	D	SPDR S&P Biotech ETF	2.5

Compare ETFs

Compare BBP to PBE Compare BBP to XBI Compare PSCH to XBI

Date	Stock	Title
Nov 22	IOVA	2 Innovative Stocks That Could Deliver Outsize Returns
Nov 22	IOVA	Iovance Biotherapeutics Inc. (IOVA): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts
Nov 21	IBRX	ImmunityBio and nCartes Enter Collaboration Agreement on Clinical Trial Data Fulfillment
Nov 21	GRI	GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)
Nov 21	TGTX	TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
Nov 20	IBRX	High Growth Tech Stocks To Watch In November 2024
Nov 20	CELU	Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific
Nov 20	GDTC	Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced Solid Tumours or Haematological Malignancies
Nov 19	IBRX	ImmunityBio Completes ANKTIVA’s Post-Approval Enrollment of the 100th Patient in BCG Unresponsive NMIBC CIS Trial and Reports a Complete Response Rate of 71% with a Durable Duration of Response Ranging Up to 54 Months
Nov 18	CELU	Celularity announces resolution of Nasdaq listing compliance matter
Nov 18	CELU	Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter

Lymphocytes: A lymphocyte is a type of white blood cell in the vertebrate immune system. Lymphocytes include natural killer cells (which function in cell-mediated, cytotoxic innate immunity), T cells (for cell-mediated, cytotoxic adaptive immunity), and B cells (for humoral, antibody-driven adaptive immunity). They are the main type of cell found in lymph, which prompted the name "lymphocyte".Lymphocytes make up between 18% and 42% of circulating leukocytes.